Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus versus cyclosporine after de novo cardiac transplant with mycophenolic acid
2015-001041-83Phase 3
- Sponsor
- Astellas Pharma
- Start
- Apr 2015
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus, cyclosporine, mycophenolic acid in Cardiac Rejection, sponsored by Astellas Pharma.
02
Drugs
tacrolimuscyclosporinemycophenolic acid
03
Conditions
Cardiac Rejection
Beyond the preview
Go deeper on 2015-001041-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001041-83.